Conserved host-pathogen interactions identify novel treatment options in betacoronavirus infections
Open Access
- 10 February 2021
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Signal Transduction and Targeted Therapy
- Vol. 6 (1), 1-3
- https://doi.org/10.1038/s41392-021-00480-z
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanismsScience, 2020
- Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trialThe Lancet Respiratory Medicine, 2020
- Inborn errors of type I IFN immunity in patients with life-threatening COVID-19Science, 2020
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19Science, 2020
- A SARS-CoV-2 protein interaction map reveals targets for drug repurposingNature, 2020
- A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-RepurposingPublished by Cold Spring Harbor Laboratory ,2020